Last reviewed · How we verify
NCT04212819
Before and After Erythrocyte Suspension Transfusion
NA trial testing Before Erythrocyte Suspension (ES) in Anemia in 50 participants. Completed in 31 December 2015.
1 April 2015
Quick facts
| Lead sponsor | Afyonkarahisar Health Sciences University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 50 |
| Start date | 1 January 2014 |
| Primary completion | 1 April 2015 |
| Estimated completion | 31 December 2015 |
Drugs / interventions tested
- Before Erythrocyte Suspension (ES)
- After Erythrocyte Suspension (ES)
Conditions studied
- Anemia — all drugs for Anemia →
- Oxidative Stress — all drugs for Oxidative Stress →
Sponsor
Afyonkarahisar Health Sciences University
Who can join
Adults 18 to 80, any sex, with Anemia or Oxidative Stress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hypoperfusion, hypoxia and ischemia occurs in circulation as a result of anemia. All of these situations lead to oxidative stress and endothelial dysfunction in the organism. In this study, the investigators aimed to investigate the oxidant-antioxidant balance and asymmetric dimethylarginine (ADMA) levels in patients that have symptomatic anemia in need of erythrocyte suspension (ES) transfusion. To the best of the investigators knowledge, there have been few studies in the literature on anemia and total oxidant, total antioxidant and ADMA levels. We aimed to observe changes in oxidative - antioxidant ADMA levels before and after ES transfusion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04212819
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anemia
Currently open trials in the same condition.
- NCT07422480 — A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel · Phase 3 · recruiting
- NCT06968936 — Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy · NA · recruiting
- NCT07328191 — Quality of Life-Guided Transfusion in Refractory MDS or AML · NA · recruiting
- NCT07315295 — Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya · NA · recruiting
- NCT07400796 — Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia · recruiting
Other Afyonkarahisar Health Sciences University trials
Trials by the same sponsor.
- NCT07482501 — Repetitive Transcranial Magnetic Stimulation in Cardiac Autonomic Dysfunction · NA · recruiting
- NCT07445594 — Effect of Play Dough, Slime, and Plush Toys on Dental Anxiety and Pain in Children During Dental Treatment · NA · not yet recruiting
- NCT07421206 — DETERMINATION OF THE EFFECTS OF STAINLESS STEEL CROWNS CEMENTED WITH RESIN CEMENTS ON INTERLEUKIN-10, 12, 18 LEVELS IN G · NA · not yet recruiting
- NCT07340385 — Physiological and Biochemical Responses to Blood Flow Restriction Training · recruiting
- NCT07312812 — The Effect of Art-Based Mandala Coloring Activity on Postpartum Anxiety and Postpartum Depression · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04212819 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Afyonkarahisar Health Sciences University
- Last refreshed: 2 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04212819.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing